甲状腺滤泡性肿瘤的诊断研究进展  

Research Progress in Diagnosis of Follicular Thyroid Carcinoma

作　　者：潘永勤[1] 徐铭禧 李进义[1] 杨华[2] PAN Yongqin;XU Mingxi;LI Jinyi;YANG Wah(Department of Thyroid Surgery,the First Affiliated Hospital of Jinan University,Guangzhou 510632,China;Department of Gastrointestinal Surgery,the First Affiliated Hospital of Jinan University,Guangzhou 510632,China)

机构地区：[1]暨南大学附属第一医院甲状腺外科,广州510632 [2]暨南大学附属第一医院胃肠外科,广州510632

出　　处：《医学综述》2024年第8期945-950,共6页Medical Recapitulate

基　　金：广州市科技计划项目(202102010120)。

摘　　要：甲状腺滤泡状癌(FTC)不同于甲状腺滤泡性腺瘤,其特征为细胞的异型性以及包膜和血管浸润。由于肿瘤的良恶性只能通过术后病理鉴别,绝大部分滤泡性腺瘤患者采取诊断性腺叶切除,但接受腺叶切除的患者术后绝大部分为良性,因此目前亟须寻找一种针对FTC的额外诊断补充依据。术前评估肿瘤的良恶性可减少不必要的手术伤害和短期甚至长期的药物补充治疗。未来全面了解甲状腺滤泡性肿瘤的诊断进展,可以为疾病的治疗提供新思路。Follicular thyroid carcinoma(FTC)is distinct from follicular thyroid adenoma,characterized by cellular atypia,capsule and vascular invasion.As benign and malignant tumors can only be distinguished by postoperative pathology,most patients suspected of follicular thyroid adenoma undergo diagnostic lobectomy,while most of the patients are postopertively diagnosed with benign tumors,highlighting the need for additional diagnostic methods for FTC.Preoperative assessment of benign or malignant nature can reduce unnecessary surgical trauma and short-term or even long-term drug supplementation.A comprehensive understanding of the progress in the diagnosis of thyroid follicular tumor,can contribute new ideas to the treatment.

关 键 词：甲状腺癌 滤泡性肿瘤 诊断 

分 类 号：R604[医药卫生—外科学] R736[医药卫生—临床医学]